Comparison of Nutrigenomics Technology Interface Tools for Consumers and Health Professionals: A Sequential Explanatory Mixed Methods Investigation

Vanessa Araujo Almeida, Paula Littlejohn, Irene Cop, Erin Brown, Rimi Afroze, Karen M Davison, Vanessa Araujo Almeida, Paula Littlejohn, Irene Cop, Erin Brown, Rimi Afroze, Karen M Davison

Abstract

Background: Nutrigenomics forms the basis of personalized nutrition by customizing an individual's dietary plan based on the integration of life stage, current health status, and genome information. Some common genes that are included in nutrition-based multigene test panels include CYP1A2 (rate of caffeine break down), MTHFR (folate usage), NOS3 (risk of elevated triglyceride levels related to omega-3 fat intake), and ACE (blood pressure response in related to sodium intake). The complexity of gene test-based personalized nutrition presents barriers to its implementation.

Objective: This study aimed to compare a self-driven approach to gene test-based nutrition education versus an integrated practitioner-facilitated method to help develop improved interface tools for personalized nutrition practice.

Methods: A sequential, explanatory mixed methods investigation of 55 healthy adults (35 to 55 years) was conducted that included (1) a 9-week randomized controlled trial where participants were randomized to receive a standard nutrition-based gene test report (control; n=19) or a practitioner-facilitated personalized nutrition intervention (intervention; n=36) and (2) an interpretative thematic analysis of focus group interview data. Outcome measures included differences in the diet quality score (Healthy Eating Index-Canadian [HEI-C]; proportion [%] of calories from total fat, saturated fat, and sugar; omega 3 fatty acid intake [grams]; sodium intake [milligrams]); as well as health-related quality of life (HRQoL) scale score.

Results: Of the 55 (55/58 enrolled, 95%) participants who completed the study, most were aged between 40 and 51 years (n=37, 67%), were female (n=41, 75%), and earned a high household income (n=32, 58%). Compared with baseline measures, group differences were found for the percentage of calories from total fat (mean difference [MD]=-5.1%; Wilks lambda (λ)=0.817, F1,53=11.68; P=.001; eta-squared [η²]=0.183) and saturated fat (MD=-1.7%; λ=0.816; F1,53=11.71; P=.001; η²=0.18) as well as HRQoL scores (MD=8.1 points; λ=0.914; F1,53=4.92; P=.03; η²=0.086) compared with week 9 postintervention measures. Interactions of time-by-group assignment were found for sodium intakes (λ=0.846; F1,53=9.47; P=.003; η²=0.15) and HEI-C scores (λ=0.660; F1,53=27.43; P<.001; η²=0.35). An analysis of phenotypic and genotypic information by group assignment found improved total fat (MD=-5%; λ=0.815; F1,51=11.36; P=.001; η²=0.19) and saturated fat (MD=-1.3%; λ=0.822; F1,51=10.86; P=.002; η²=0.18) intakes. Time-by-group interactions were found for sodium (λ=0.844; F3,51=3.09; P=.04; η²=0.16); a post hoc analysis showed pre/post differences for those in the intervention group that did (preintervention mean 3611 mg, 95% CI 3039-4182; postintervention mean 2135 mg, 95% CI 1564-2705) and did not have the gene risk variant (preintervention mean 3722 mg, 95% CI 2949-4496; postintervention mean 2071 mg, 95% CI 1299-2843). Pre- and postdifferences related to the Dietary Reference Intakes showed increases in the proportion of intervention participants within the acceptable macronutrient distribution ranges for fat (pre/post mean difference=41.2%; P=.02). Analysis of textual data revealed 3 categories of feedback: (1) translation of nutrition-related gene test information to action; (2) facilitation of eating behavior change, particularly for the macronutrients and sodium; and (3) directives for future personalized nutrition practice.

Conclusions: Although improvements were observed in both groups, healthy adults appear to derive more health benefits from practitioner-led personalized nutrition interventions. Further work is needed to better facilitate positive changes in micronutrient intakes.

Trial registration: ClinicalTrials.gov NCT03310814; https://ichgcp.net/clinical-trials-registry/NCT03310814.

International registered report identifier (irrid): RR2-10.2196/resprot.9846.

Keywords: epigenomics; genomics; interface, user-computer; nutrigenetics; nutrigenomics.

Conflict of interest statement

Conflicts of Interest: PL provides Web-based nutrigenomics education. No other conflicts of interest are declared.

©Vanessa Araujo Almeida, Paula Littlejohn, Irene Cop, Erin Brown, Rimi Afroze, Karen M Davison. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 28.06.2019.

Figures

Figure 1
Figure 1
Examples from educational tools.
Figure 2
Figure 2
Participant selection.
Figure 3
Figure 3
Time-by-group interactions for sodium and diet quality scores.

References

    1. Simopoulos AP. Nutrigenetics/Nutrigenomics. Annu Rev Public Health. 2010;31:53–68. doi: 10.1146/annurev.publhealth.031809.130844.
    1. De Caterina R. Genetic and nutritional interactions in cardiovascular disease. World Rev Nutr Diet. 2011;102:150–5. doi: 10.1159/000327803.
    1. Tammen SA, Friso S, Choi S. Epigenetics: the link between nature and nurture. Mol Aspects Med. 2013 Jul;34(4):753–64. doi: 10.1016/j.mam.2012.07.018.
    1. Berná G, Oliveras-López MJ, Jurado-Ruíz E, Tejedo J, Bedoya F, Soria B, Martín F. Nutrigenetics and nutrigenomics insights into diabetes etiopathogenesis. Nutrients. 2014 Nov 21;6(11):5338–69. doi: 10.3390/nu6115338.
    1. Mathers JC. Nutrigenomics in the modern era. Proc Nutr Soc. 2017 Dec;76(3):265–75. doi: 10.1017/S002966511600080X.
    1. El-Sohemy A, Cornelis MC, Kabagambe EK, Campos H. Coffee, CYP1A2 genotype and risk of myocardial infarction. Genes Nutr. 2007 Oct;2(1):155–6. doi: 10.1007/s12263-007-0043-4.
    1. Palatini P, Ceolotto G, Ragazzo F, Dorigatti F, Saladini F, Papparella I, Mos L, Zanata G, Santonastaso M. CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension. J Hypertens. 2009 Aug;27(8):1594–601. doi: 10.1097/HJH.0b013e32832ba850.
    1. Solis C, Veenema K, Ivanov AA, Tran S, Li R, Wang W, Moriarty DJ, Maletz CV, Caudill MA. Folate intake at RDA levels is inadequate for Mexican American men with the methylenetetrahydrofolate reductase 677TT genotype. J Nutr. 2008 Jan;138(1):67–72. doi: 10.1093/jn/138.1.67.
    1. Guinotte CL, Burns MG, Axume JA, Hata H, Urrutia TF, Alamilla A, McCabe D, Singgih A, Cogger EA, Caudill MA. Methylenetetrahydrofolate reductase 677C-->T variant modulates folate status response to controlled folate intakes in young women. J Nutr. 2003 May;133(5):1272–80. doi: 10.1093/jn/133.5.1272.
    1. Tsang BL, Devine OJ, Cordero AM, Marchetta CM, Mulinare J, Mersereau P, Guo J, Qi YP, Berry RJ, Rosenthal J, Crider KS, Hamner HC. Assessing the association between the methylenetetrahydrofolate reductase (MTHFR) 677C>T polymorphism and blood folate concentrations: a systematic review and meta-analysis of trials and observational studies. Am J Clin Nutr. 2015 Jun;101(6):1286–94. doi: 10.3945/ajcn.114.099994.
    1. Ferguson JF, Phillips CM, McMonagle J, Pérez-Martínez P, Shaw DI, Lovegrove JA, Helal O, Defoort C, Gjelstad IMF, Drevon CA, Blaak EE, Saris WHM, Leszczyńska-Gołabek I, Kiec-Wilk B, Risérus U, Karlström B, Lopez-Miranda J, Roche HM. NOS3 gene polymorphisms are associated with risk markers of cardiovascular disease, and interact with omega-3 polyunsaturated fatty acids. Atherosclerosis. 2010 Aug;211(2):539–44. doi: 10.1016/j.atherosclerosis.2010.03.027.
    1. Poch E, González D, Giner V, Bragulat E, Coca A, de La Sierra A. Molecular basis of salt sensitivity in human hypertension. Evaluation of renin-angiotensin-aldosterone system gene polymorphisms. Hypertension. 2001 Nov;38(5):1204–9.
    1. Edwards KT, Huang CJ. Bridging the consumer-medical divide: how to regulate direct-to-consumer genetic testing. Hastings Cent Rep. 2014 May;44(3):17–9. doi: 10.1002/hast.310.
    1. Covolo L, Rubinelli S, Ceretti E, Gelatti U. Internet-based direct-to-consumer genetic testing: a systematic review. J Med Internet Res. 2015 Dec 14;17(12):e279. doi: 10.2196/jmir.4378.
    1. Goldsmith L, Jackson L, O'Connor A, Skirton H. Direct-to-consumer genomic testing from the perspective of the health professional: a systematic review of the literature. J Community Genet. 2013 Apr;4(2):169–80. doi: 10.1007/s12687-012-0135-8.
    1. Nielsen DE, El-Sohemy A. Disclosure of genetic information and change in dietary intake: a randomized controlled trial. PLoS One. 2014 Nov;9(11):e112665. doi: 10.1371/journal.pone.0112665.
    1. Livingstone KM, Celis-Morales C, Navas-Carretero S, San-Cristobal R, Macready AL, Fallaize R, Forster H, Woolhead C, O'Donovan CB, Marsaux CF, Kolossa S, Tsirigoti L, Lambrinou CP, Moschonis G, Godlewska M, Surwiłło A, Drevon CA, Manios Y, Traczyk I, Gibney ER, Brennan L, Walsh MC, Lovegrove JA, Saris WH, Daniel H, Gibney M, Martinez JA, Mathers JC, Food4Me Study Effect of an internet-based, personalized nutrition randomized trial on dietary changes associated with the Mediterranean diet: the Food4Me Study. Am J Clin Nutr. 2016 Aug;104(2):288–97. doi: 10.3945/ajcn.115.129049.
    1. Fallaize R, Celis-Morales C, Macready AL, Marsaux CF, Forster H, O'Donovan C, Woolhead C, San-Cristobal R, Kolossa S, Hallmann J, Mavrogianni C, Surwillo A, Livingstone KM, Moschonis G, Navas-Carretero S, Walsh MC, Gibney ER, Brennan L, Bouwman J, Grimaldi K, Manios Y, Traczyk I, Drevon CA, Martinez JA, Daniel H, Saris WH, Gibney MJ, Mathers JC, Lovegrove JA, Food4Me Study The effect of the apolipoprotein E genotype on response to personalized dietary advice intervention: findings from the Food4Me randomized controlled trial. Am J Clin Nutr. 2016 Sep;104(3):827–36. doi: 10.3945/ajcn.116.135012.
    1. O'Donovan CB, Walsh MC, Gibney MJ, Brennan L, Gibney ER. Knowing your genes: does this impact behaviour change? Proc Nutr Soc. 2017 Dec;76(3):182–91. doi: 10.1017/S0029665116002949.
    1. Celis-Morales C, Marsaux CF, Livingstone KM, Navas-Carretero S, San-Cristobal R, Fallaize R, Macready AL, O'Donovan C, Woolhead C, Forster H, Kolossa S, Daniel H, Moschonis G, Mavrogianni C, Manios Y, Surwillo A, Traczyk I, Drevon CA, Grimaldi K, Bouwman J, Gibney MJ, Walsh MC, Gibney ER, Brennan L, Lovegrove JA, Martinez JA, Saris WH, Mathers JC. Can genetic-based advice help you lose weight? Findings from the Food4Me European randomized controlled trial. Am J Clin Nutr. 2017 May;105(5):1204–13. doi: 10.3945/ajcn.116.145680.
    1. Littlejohn P, Cop I, Brown E, Afroze R, Davison KM. Comparison of nutrigenomics technology interface tools for consumers and health professionals: protocol for a mixed-methods study. JMIR Res Protoc. 2018 Jun 11;7(6):e115. doi: 10.2196/resprot.9846.
    1. Institute of Medicine . Dietary Reference Intakes: Applications in Dietary Assessment. Washington, USA: National Academies Press; 2001.
    1. Health Canada . Eating Well With Canada's Food Guide. Ottawa, Canada: Health Canada; 2007.
    1. British Columbia Government . British Columbia Nutrition Survey - Report on Food Group Use. Victoria, Canada: BC Ministry of Health Services; 2004.
    1. Grimaldi KA, van Ommen B, Ordovas JM, Parnell LD, Mathers JC, Bendik I, Brennan L, Celis-Morales C, Cirillo E, Daniel H, de Kok B, El-Sohemy A, Fairweather-Tait SJ, Fallaize R, Fenech M, Ferguson LR, Gibney ER, Gibney M, Gjelstad IMF, Kaput J, Karlsen AS, Kolossa S, Lovegrove J, Macready AL, Marsaux CFM, Alfredo MJ, Milagro F, Navas-Carretero S, Roche HM, Saris WHM, Traczyk I, van Kranen H, Verschuren L, Virgili F, Weber P, Bouwman J. Proposed guidelines to evaluate scientific validity and evidence for genotype-based dietary advice. Genes Nutr. 2017 Dec;12:35. doi: 10.1186/s12263-017-0584-0.
    1. SurveyMonkey Inc. 2017. .
    1. Eysenbach G. Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES) J Med Internet Res. 2004 Sep 29;6(3):e34. doi: 10.2196/jmir.6.3.e34.
    1. Health Canada . BC Nutrition Survey Training Manual. Ottawa, Canada: Health Canada; 1999.
    1. Garriguet D. Diet quality in Canada. Health Rep. 2009 Sep;20(3):41–52.
    1. Lowe MR. The effects of dieting on eating behavior: a three-factor model. Psychol Bull. 1993 Jul;114(1):100–21.
    1. Turner-Bowker DM, Bayliss MS, Ware JE, Kosinski M. Usefulness of the SF-8 Health Survey for comparing the impact of migraine and other conditions. Qual Life Res. 2003 Dec;12(8):1003–12.
    1. Ware J, Kosinski M, Dewey J, Gandek B. How to Score and Interpret Single-Item Health Status Measures: A Manual for Users of the SF-8 Health Survey. Boston, USA: QualyMetric; 2001.
    1. Schwarzer R, Jerusalem M. Generalized Self-Efficacy Scale. In: Weinman J, Wright S, Johnston M, editors. Measures in health psychology: A User's Portfolio. Causal and Control Beliefs. Windsor, England: NFER-NELSON; 1995.
    1. Luszczynska A, Scholz U, Schwarzer R. The general self-efficacy scale: multicultural validation studies. J Psychol. 2005 Sep;139(5):439–57. doi: 10.3200/JRLP.139.5.439-457.
    1. Prochaska JO, DiClemente CC. Stages of change in the modification of problem behaviors. Prog Behav Modif. 1992;28:183–218.
    1. Taylor HL, Jacobs DR, Schucker B, Knudsen J, Leon AS, Debacker G. A questionnaire for the assessment of leisure time physical activities. J Chronic Dis. 1978;31(12):741–55.
    1. Statistics Canada . Canadian Community Health Survey. Ottawa, Canada: Statistics Canada; 2010. .
    1. Yu L, Buysse DJ, Germain A, Moul DE, Stover A, Dodds NE, Johnston KL, Pilkonis PA. Development of short forms from the PROMIS™ sleep disturbance and sleep-related impairment item banks. Behav Sleep Med. 2011 Dec 28;10(1):6–24. doi: 10.1080/15402002.2012.636266.
    1. ESHA Research: Food Labeling Software | Nutrition Analysis Software. Salem, OR: USAHA Research; 2017. Food Processor SQL
    1. Health Canada . Canadian Nutrient File. Ottawa, Canada: Health Canada; 2016.
    1. Stata Corporation . Stata Statistical Software: Release 2. College Station, USA: Stata Corporation; 2011.
    1. NVivo qualitative data analysis software, Version 11. Victoria, Australia: QSR International Pty Ltd; 2015. .
    1. Sandelowski M. Qualitative analysis: what it is and how to begin. Res Nurs Health. 1995 Aug;18(4):371–5.
    1. Forster H, Walsh MC, O'Donovan CB, Woolhead C, McGirr C, Daly EJ, O'Riordan R, Celis-Morales C, Fallaize R, Macready AL, Marsaux CF, Navas-Carretero S, San-Cristobal R, Kolossa S, Hartwig K, Mavrogianni C, Tsirigoti L, Lambrinou CP, Godlewska M, Surwiłło A, Gjelstad IM, Drevon CA, Manios Y, Traczyk I, Martinez JA, Saris WH, Daniel H, Lovegrove JA, Mathers JC, Gibney MJ, Gibney ER, Brennan L. A dietary feedback system for the delivery of consistent personalized dietary advice in the web-based multicenter Food4Me study. J Med Internet Res. 2016 Jun 30;18(6):e150. doi: 10.2196/jmir.5620.
    1. Marteau TM, French DP, Griffin SJ, Prevost AT, Sutton S, Watkinson C, Attwood S, Hollands GJ. Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours. Cochrane Database Syst Rev. 2010 Oct 6;(10):CD007275. doi: 10.1002/14651858.CD007275.pub2.
    1. Rankin A, Bunting BP, Poínhos R, van der Lans IA, Fischer AR, Kuznesof S, Almeida M, Markovina J, Frewer LJ, Stewart-Knox BJ. Food choice motives, attitude towards and intention to adopt personalised nutrition. Public Health Nutr. 2018 Oct;21(14):2606–16. doi: 10.1017/S1368980018001234.
    1. O'Donovan CB, Walsh MC, Forster H, Woolhead C, Celis-Morales C, Fallaize R, Macready AL, Marsaux CF, Navas-Carretero S, San-Cristobal R, Kolossa S, Mavrogianni C, Lambrinou CP, Moschonis G, Godlewska M, Surwillo A, Bouwman J, Grimaldi K, Traczyk I, Drevon CA, Daniel H, Manios Y, Martinez JA, Saris WH, Lovegrove JA, Mathers JC, Gibney MJ, Brennan L, Gibney ER. The impact of 677C → T risk knowledge on changes in folate intake: findings from the Food4Me study. Genes Nutr. 2016;11:25. doi: 10.1186/s12263-016-0539-x.
    1. NCD Risk Factor Collaboration (NCD-RisC) Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet. 2017 Dec 7;389(10064):37–55. doi: 10.1016/S0140-6736(16)31919-5.
    1. Global Health Observatory (GHO) data. Geneva, Switzerland: World Health Organization; 2015. .
    1. Jing X, Chen J, Dong Y, Han D, Zhao H, Wang X, Gao F, Li C, Cui Z, Liu Y, Ma J. Related factors of quality of life of type 2 diabetes patients: a systematic review and meta-analysis. Health Qual Life Outcomes. 2018 Sep 19;16(1):189. doi: 10.1186/s12955-018-1021-9.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner